FSHR负变构调节剂对LH/CGR的分析揭示了具有类固醇生成意义的偏倚拮抗作用
Profiling of FSHR Negative Allosteric Modulators on LH/CGR Reveals Biased Antagonism with Implications in Steroidogenesis
摘要:
最近出现的偏置信号作为一个有趣的手段来调节许多G蛋白偶联受体(GPCRs)的功能。先前的研究报道了两种卵泡刺激素受体(FSHR)的负变构调节剂(NAM),ADX 68692和ADX 68693,对FSHR介导的类固醇生成和排卵具有不同的作用。在这项研究中,我们试图在HEK 293细胞中对密切相关的促黄体生成/绒毛膜促性腺激素受体(LH/CGR)的经典Gs/cAMP通路以及β-arrestin募集进行分析。还在鼠Leydig肿瘤细胞系(mLTC-1)中评估NAMs对孕酮和睾酮产生的作用。我们发现两种NAMS都强烈拮抗HEK 293和mLTC-1细胞中的LH/CGR信号传导。在HEK 293和mLTC-1细胞中,ADX 68693抑制hCG诱导的cAMP和β-arrestin 2的效力似乎比ADX 68692更强,但它们对hCG促进的β-arrestin 2募集的效力无显著差异。有趣的是,在mLTC-1细胞中观察到两种NAM对hCG促进的类固醇生成的差异性拮抗作用,显著抑制睾酮但不抑制孕酮的产生。这些观察结果表明两种NAMS对LH/CGRP依赖性途径控制类固醇生成的偏倚效应,这似乎与先前在FSHR上显示的不同。这也说明了控制FSHR和LH/CGRP介导的类固醇生成的信号通路的复杂性,提示cAMP和β-抑制蛋白的不同意义。总之,我们的数据表明,ADX 68692和ADX 68693在LH/CGR以及FSHR下均为NAM。这些药理学特性对于考虑基于此类化合物的潜在避孕和治疗应用是重要的。
英文摘要:
Biased signaling has recently emerged as an interesting mean to modulate the function of many G protein-coupled receptors (GPCRs). Previous studies reported two negative allosteric modulators (NAMs) of follicle-stimulating hormone receptor (FSHR), ADX68692 and ADX68693, with differential effects on FSHR-mediated steroidogenesis and ovulation. In this study, we attempted to pharmacologically profile these NAMs on the closely related luteinizing/chorionic gonadotropin hormone receptor (LH/CGR) with regards to its canonical Gs/cAMP pathway as well as β-arrestin recruitment in HEK293 cells. The NAMs effects on progesterone and testosterone production were also assessed in murine Leydig tumor cell line (mLTC-1). We found that both NAMs strongly antagonized LH/CGR signaling in both HEK293 and mLTC-1 cells. ADX68693 appeared more potent than ADX68692 to inhibit hCG-induced cAMP and β-arrestin 2 in HEK293 and mLTC-1 cells whereas no significant difference in their efficacy on hCG-promoted β-arrestin 2 recruitment. Interestingly, differential antagonism of the two NAMs on hCG-promoted steroidogenesis in mLTC-1 cells was observed with significant inhibition of testosterone but not progesterone production. These observations suggest biased effects of the two NAMs on LH/CGR-dependent pathways controlling steroidogenesis, which appeared to be different to that previously shown on FSHR. This also illustrates the complexity of signaling pathways controlling FSHR- and LH/CGR-mediated steroidogenesis, suggesting differential implication of cAMP and β-arrestins. Together, our data demonstrate that ADX68692 and ADX68693 are NAMs at the LH/CGR in addition to FSHR. These pharmacological characteristics are important to consider for potential contraceptive and therapeutic applications based on such compounds.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。